Candel Therapeutics, Inc. (CADL): Narxning prognoz qilingan daromadga nisbati
Candel Therapeutics (CADL) uchun xavflar faqat ekologik qoidalarga rasmiy rioya qilish va reagentlarni utilizatsiya qilish bilan cheklangan. Emitentning forward P/S ko'rsatkichi ushbu jihatlarni vizuallashtiradi, bunda 1523.70 belgisi joriy holatni ko'rsatadi. Barqarorlik virusli platformalarning patent himoyasi va tartibga solish murakkabligi bilan ta'minlangan. O'sish potentsiali metastazlarni yo'q qilishning noyob usullariga bo'lgan elastik bo'lmagan talabga asoslangan bo'lib, bu Candel Therapeutics (CADL) uchun yuqori narx belgilash imkoniyatini kafolatlaydi.
candeltx.com (CADL) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Candel Therapeutics|CADL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Candel Therapeutics, Inc.|CADL - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati Candel Therapeutics, Inc.|CADL - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Candel Therapeutics|Tezkor likvidlik koeffitsiyenti candeltx.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
CADL - Kompaniyaning sof daromadi|Kutilayotgan foyda Candel Therapeutics|CADL - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Candel Therapeutics, Inc.|CADL - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Candel Therapeutics, Inc.|CADL - Foizlar, soliqlar, eskirish va amortizatsiya chegirilmasdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Candel Therapeutics|CADL - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi candeltx.com|CADL - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Candel Therapeutics
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Candel (CADL)
Biofarmatsevtika sektorida himoya portfelini shakllantirish uchun prognoz qilingan daromadga nisbatan bozor qiymatini skrining qilish juda muhimdir. Ushbu metrika Candel Therapeutics (CADL) kapitalizatsiyasini kutilayotgan savdo hajmi bilan bog'lab, makroiqtisodiy tendentsiyalardan mustaqil bo'lib qolgan dori ishlab chiqish sikli doirasida aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlaydi. Candel Therapeutics (CADL) uchun kutilayotgan P/S grafigini tahlil qilish joriy kotirovkalarning biznesning fundamental istiqbollariga nisbatan adolatli ekanligini baholash imkonini beradi.
Raqobatdosh kompaniyalar
Forvard P/S multiplikatori ONC (BeiGene)|Forvard P/S multiplikatori Halozyme Therapeutics, Inc. HALO|RVMD - Narxning prognoz qilingan daromadga nisbati|AAPG (Ascentage Pharma Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|CGON: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati URGN|BCAX (Bicara Therapeutics) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Inc PSNL|Narxning prognoz qilingan daromadga nisbati Erasca Corp (ERAS)|Narxning prognoz qilingan daromadga nisbati DCTH (Delcath Corp)|Y-mAbs Therapeutics - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AURA|ARAY: Forvard narx/daromad multiplikatori|SELLAS Life Sciences - Narxning kutilayotgan daromadga nisbati|ACTU: Forvard P/S multiplikatori|Citius Oncology Inc - Sotuvga nisbatan forvard narx|HURA (TuHURA Biosciences Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati protaratx.com TARA|Narxning prognoz qilingan daromadga nisbati Fate Therapeutics (FATE)|WHWK (aadibio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori TCRX (TScan Therapeutics, Inc.)|Forvard P/S multiplikatori Champions Oncology Inc CSBR|XBIT - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CVM|OSTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati radiopharmtheranostics.com (RADX)|Forvard narx/daromad multiplikatori ARTV|Forvard P/S multiplikatori Adlai Nortye Limited|Forvard narx/daromad multiplikatori VERU (Veru Inc.)|Narxning kutilayotgan daromadga nisbati TPST|Forvard P/S multiplikatori XLO (Xilio Therapeutics)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Renovaro Biosciences (RENB)|Mural Bio - Forvard P/S multiplikatori|Kairos Pharma Ltd (KAPA) - Forvard narx/daromad multiplikatori|onkuretherapeutics.com (OKUR) - Narxning prognoz qilingan daromadga nisbati|GDTC - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|CRIS (Curis Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Apollomics Corp (APLM)|Forvard P/S multiplikatori THAR|Forvard P/S multiplikatori advanbiomed.com (ADVB)|Forvard P/S multiplikatori GNPX (Genprex, Inc.)|CLDI: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|SBFM - Narxning prognoz qilingan daromadga nisbati|XBIO: Narxning prognoz qilingan daromadga nisbati|SLRX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Kitov Pharma|AONC (American Oncology Network Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori beigene.com|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|elevationoncology.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori ICAD (iCAD)|IKNA - Forvard narx/daromad multiplikatori|Notable Labs, Ltd. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Viracta Therapeutics|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Inc - Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori AAPGV
